US FTC Accuses Hims & Hers of Sending User Health Data to Meta and Snap
The US Federal Trade Commission (FTC) has filed a lawsuit against telehealth company Hims & Hers, alleging that the company transmitted users' sensitive health information to social media platforms such as Meta and Snap without authorization. According to the FTC, this data sharing occurred without users' explicit consent and violated the privacy of personal health data.
The complaint states that Hims & Hers used third-party tracking codes embedded on its website to share information with Meta and Snap, including details about which health services users accessed and which medications they purchased. The FTC emphasizes that this practice was deceptive to consumers and contradicted the commitments outlined in the company's privacy policies.
The FTC demands that Hims & Hers cease this data sharing and implement stricter measures to protect user data. Additionally, the company is required to establish an independent oversight mechanism for its future data collection and sharing practices. The Commission warns that it may impose additional penalties, including fines, if such violations recur.
Hims & Hers has not yet issued an official statement on the matter. However, the company has previously stated that it has taken steps to protect user data in similar cases. This lawsuit reignites concerns about digital privacy in the healthcare sector while reinforcing the FTC's regulatory role in this area.
This is not investment advice.
📊 HIMS — Piyasa Yorumu
▼ down · 70%The news points to an FTC investigation into allegations that the company shared user data without authorization, which could weigh on the stock. Technical indicators are already weak: the price is below both the 20-day and 50-day moving averages, and the RSI at 33 is near oversold territory but has yet to signal a recovery. The MACD line is below the signal line and in negative territory, confirming bearish momentum. While the 10.8% drop over the past 24 hours has partially priced in the news, the risk of continued selling pressure in the near term remains high. However, the oversold zone and low price levels also raise the possibility of some bargain buying.
RSI 14
32.9
MACD
-1.09
24h Δ
-10.85%
Canlı Grafikler
🔗 İlgili haberler
⭐ 75 · 25.06
Hims obezite ilacı işine, işverenlerin kapsamı düşürmesiyle destek gelebilir
⭐ 63 · 02.06
Hims & Hers, Eucalyptus'u Satın Alarak Japonya Pazarına Girdi
⭐ 63 · 21.05
Hims & Hers, Kanada'da GLP-1 Piyasasına Giriyor, Hisse Değeri Artıyor
⭐ 63 · 21.05
Hims & Hers, Kanada'da Jenerik Semaglutidi Aylık 149 Dolara Sunuyor
⭐ 67 · 12.05
Hims & Hers Health Hisseleri Sert Düşüş Yaşadı
⭐ 85 · 12.05
Under Armour Tahmini Eksik, Wendy's Özel Teklif, Hims & Hers Kayıp
🧬 Buna benzer
⭐ 65
ABD SEC, Hintli milyarder Adani'ye karşı açtığı davayı mahkeme onayına tabi olarak sonlandırdı
⭐ 67
İngiltere mahkemesi Apple'a karşı iCloud davasını onayladı
⭐ 67
GM, Sürücü Verilerinin Satışı Nedeniyle Kaliforniya ile Uzlaştı
⭐ 72
CME, Kalshi ve Coinbase'e Sürekli Vadeli İşlem İzni Nedeniyle CFTC'ye Dava Açtı
AI tarafından yeniden derlenmiştir. Yatırım tavsiyesi değildir.